Relationship of Ras,MAPK and CyclinD1 Pathway in Carcinogenesis of Cutaneous Pathologic Scar
-
摘要: 目的 探讨Ras/Raf/MAPK信号通路及其通路下游靶基因CyclinD1与病理性瘢痕癌变的相关性。 方法 （1） 激光扫描共聚焦显微技术，对病理性瘢痕和瘢痕癌组织进行K-ras、H-ras、N-ras免疫荧光双标记。（2）免疫组织化学SP法分别检测正常皮肤、病理性瘢痕和瘢痕癌三组组织中MAPK、CyclinD1蛋白的表达。（3）原位杂交技术检测三组组织中MAPK mRNA、CyclinD1 mRNA的表达。（4）用基因测序技术，检测病理性瘢痕上皮中K-ras、H-ras、N-ras第12、13位密码子突变。 结果 （1）免疫荧光双标记：K-ras、H-ras、N-ras在病理性瘢痕上皮中呈现较弱荧光，为弱阳性表达；在瘢痕癌组织中呈现较强荧光，为强阳性表达。（2）MAPK及其mRNA和CyclinD1及其mRNA在正常皮肤表皮均呈阴性或弱阳性表达，在皮肤病理性瘢痕上皮中呈弱阳性表达，在瘢痕癌组织中呈强阳性表达。瘢痕癌组表达水平（阳性面积）、表达强度（平均吸光度）与正常皮肤、病理性瘢痕组比较，差异均有统计学意义（P＜0.01）；但正常皮肤组与病理性瘢痕组比较，差异无统计学意义（P＞0.05）。（3）在病理性瘢痕中未发现K-ras、H-ras、N-ras第12、13位密码子突变。 结论 （1）Ras、MAPK、CyclinD1蛋白及其MAPK mRNA、CyclinD1 mRNA不是瘢痕上皮癌变的早期信号。（2）K-ras、H-ras、N-ras第12、13位密码子突变与病理性瘢痕上皮癌变无关。Abstract: Objective To detect the function of Ras/Raf/MAPK pathway and the downstream target gene CyclinD1 in the carcinogenesis of cutaneous pathologic scar. Methods (1) We adopted immunofluorescence dual staining for K-ras, H-ras and N-ras in the pathologic scar and carcinoma of scar, respectively, and observed under laser confocal microscopy; (2) Immunohistochemistry (IHC) for MAPK and CyclinD1 were used for normal skin, pathologic scar and carcinoma of scar, respectively; (3) In situ hybridization (ISH) was used for mRNA detection of MAPK and CyclinD1; (4) The 12th and 13th codon mutations of K-ras, H-ras and N-ras were detected by genetic sequencing. Results (1) The dual labeling of immunofluorescence of K-ras, H-ras and N-ras showed weak positive in pathologic scar, while the carcinoma of scar were strong positive. (2) ISH for mRNA of MAPK and CyclinD1 showed negative or weak positive in the normal epidermis and pathological scar, but strong positive in the carcinoma of scar. The expression level(positive area) and intensity (average optical density) between the carcinoma group and normal skin group or pathologic scar group were statistical different (P＜0.01); but without statistical difference between normal skin group and pathologic scar group (P＞0.05).(3) Genetic sequencing did not show mutation on the 12th or 13th codon. Conclusion (1) Ras, MAPK and CyclinD1 were not early signals for carcinogenesis of pathologic scar. (2) The 12th or 13th codon mutation of K-ras, H-ras and N-ras was not related with the carcinogenesis of pathologic scar.
-
Key words:
- Pathologic scar /
- Signal transduction pathway /
- CyclinD1 /
- Carcinogenesis
-
-
[1] Gul U，Kilic A．Squamous cell carcinoma developing on burn scar[J]. Ann Plast Surg，2006，56(4)：406-8． [2] Kasse AA，Betel E，Dam A，et al. Cancers in the scars of thermal burns (apropos of 67 cases）[J]. Dakar Med,1999,44（2）：206-10. [3] Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas[J]. Cancer Res, 1998, 58(9):1808-12. [4] Cui W, Wang SR, Zhu LQ, et al. A comparative study of image analysis for average optical density and positive staining coverage in immunohistochemistry[C]//2008 workshop of traditional Chinese medicine association internal medicine branch. Beijing：The traditional Chinese medicine association internal medicine branch，2008: 148-51.[崔巍,王硕仁,朱陵群,等.平均光密度值分析法和阳性染色面积分析法在免疫组化图像分析中的对比研究[C]//2008中华中医药学会内科分会中医内科学科建设研讨会论文汇编.北京：中华中医药学会内科分会，2008:148-51.] [5] Guo RZ,Zhou KM,Wang Y.Expressions and significance of CyclinA and C-myc in skin scar and skin scar carcinoma[J].Zhong Liu Fang Zhi Yan Jiu,2011,38(10):1147-50.[郭瑞珍，周开梅，王燕.CyclinA、C-myc在皮肤瘢痕及瘢痕癌组织中的表达及意义[J].肿瘤防治研究，2011，38（10）：1147-50. [6] Lee SH, Shin MS, Kim HS, et al．Somatic mutations of Fas(Apo-1/CD95)gene in cutaneous squamous cell carcinoma arising from a burn scar[J].J Invest Dermatol,2000,114(1):122-6． [7] Aydo〖AKgˇD〗du E, Yildirim S, Akz T. Is surgery an effective and adequate treatment in advanced Marjolin's ulcer?[J]．Burns，2005，31(4):421-31. [8] Braut T，Krstulja M，Kujundzi[KG-*4]c〖DD（-*1〗[HT7]＇〖DD)〗 M，et al．Epidermal growth factor receptor protein expression and gene amplification in normal,hyperplastic,and cancerous glottis tissue:immunohistochemical and fluorescent in situ hybridization study on tissue microarrays[J]．Croat Med J，2009，50（4）: 370-9． [9] Ochi K，Hasuoka H，Mizushima T，et al．A case of small pancreatic cancer diagnosed by serial follow-up studies promptly by a positive K-ras point mutation in pure pancreatic juice[J]．Am J Gastroenterol，1998，93（8）：1366-8． [10] Nindl I，Gottschling M，Krawtchenko N，et al．Low prevalence of p53，p16(INK4a) and H-ras tumour-specific mutations in low-graded actinic keratosis[J]．Br J Dermatol，2007，156（Suppl 3）:34-9． [11] Zaravinos A，Kanellou P，Spandidos DA．Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers[J]．Br J Dermatol，2010，162（2）:325-31． [12] Oba J， Nakahara T， Abe T，et al．Expression of c-Kit, p-ERK and cyclin D1 in malignant melanoma:an immunohistochemical study and analysis of prognostic value[J]．J Dermatol Sci，2011，62(2):116-23． [13] Cai SQ，Wang HJ，Zheng M，et al. The significance of STAT3 and MAPK phosphorylation and cyclinDl protein expression in skin squamous cell carcinoma[J]. Zhongguo Pi Fu Xing Bing Xue Za Zhi，2005，19（8）：449-51,454.[蔡绥勍，王海军，郑敏,等．皮肤鳞状细胞癌STAT3和MAPK磷酸化及cyclinD1蛋白表达的意义[J].中国皮肤性病学杂志，2005，19（8）：449-51,454.] [14] Hao YY,Liu LB.Expression of P27kipl and Cyclin D1 in cutaneous carcinoma tissue[J].Zhengzhou Da Xue Xue Bao（Yi Xue Ban），2008，43（2）：215-7.[郝媛媛，刘林蟠.皮肤癌组织中激酶抑制蛋白-1和周期素D1的表达[J].郑州大学学报（医学版），2008，43（2）：215-7．]
计量
- 文章访问数: 1773
- HTML全文浏览量: 23
- PDF下载量: 382
下载:
